|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/40 | (2006.01) |
| C07K 16/40 | (2013.01) | ||
| A61P 3/06 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 7/00 | (2006.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 3/06 | (2018.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61P 7/00 | (2018.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 9/10 | (2018.01) |
| (11) | Patento numeris | 3536712 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19162319.8 |
| Europos patento paraiškos padavimo data | 2012-09-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-09-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-05-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201161535392 P | 2011-09-16 | US | |
| 201161559162 P | 2011-11-14 | US | |
| 201261641321 P | 2012-05-02 | US |
| (72) |
SWERGOLD,, Gary , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591-6706,
US
|
| (54) | METHODS FOR REDUCING LIPOPROTEIN(A) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9) |
| METHODS FOR REDUCING LIPOPROTEIN(A) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9) |